HomeBCAX • NASDAQ
add
Bicara Therapeutics Inc
Previous close
$18.85
Day range
$18.32 - $19.58
Year range
$7.80 - $19.75
Market cap
1.02B USD
Avg Volume
630.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 40.68M | 97.19% |
Net income | -36.33M | -107.83% |
Net profit margin | — | — |
Earnings per share | -0.67 | 58.12% |
EBITDA | -40.65M | -97.22% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 290.17M | -44.28% |
Total assets | 424.69M | -18.98% |
Total liabilities | 21.91M | 49.87% |
Total equity | 402.78M | — |
Shares outstanding | 54.78M | — |
Price to book | 2.55 | — |
Return on assets | -23.16% | — |
Return on capital | -24.15% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -36.33M | -107.83% |
Cash from operations | -29.25M | -69.81% |
Cash from investing | -236.12M | -2,951,412.50% |
Cash from financing | 436.00K | -99.87% |
Net change in cash | -264.93M | -183.60% |
Free cash flow | -17.47M | -59.05% |
About
Founded
2018
Headquarters
Website
Employees
55
